Novartis AG is 172.9x more valuable than Biohaven Ltd. by market capitalization ($293.70 B vs $1.70 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BHVN | NVS |
|---|---|---|
| Market cap | $1.70 B | $293.70 B |
| US-listed rank | #2232 | #46 |
| Net income (latest FY) | -$738.82M | - |
| SEC filings | 265 | 947 |
Novartis AG is 172.9x more valuable than Biohaven Ltd. by market capitalization ($293.70 B vs $1.70 B).
Full pages: Biohaven Ltd. and Novartis AG, or browse the full rankings.